Bacteriotherapy in Pediatric Inflammatory Bowel Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Colitis, Irritable Bowel Syndrome (IBS), Gastrointestinal, Crohns Disease |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 12 - 21 |
| Updated: | 11/30/2013 |
| Start Date: | December 2012 |
In this study, the investigators want to see if Bacteriotherapy (also referred to as stool
transplantation) improves the symptoms and decrease inflammation in children with
Inflammatory Bowel Disease (IBD). Examples of IBD are Crohn's Disease and Ulcerative
Colitis. Additionally, researchers want to learn whether this experimental therapy delays
the need for starting additional medications to treat pediatric IBD.
Inclusion Criteria:
- Children ages 12-21 years old with a diagnosis of mild to moderate Ulcerative Colitis
or Crohn's Disease
- Willing parent to donate stool for the transplant
Exclusion Criteria:
- Severe Disease
- History of intraabdominal abscess, intraabdominal fistula or stricturing
- History of other systemic diseases
- The patient has received TNF inhibitors to treat their IBD within two months of
transplant
We found this trial at
1
site
Seattle Children's Hospital Seattle Children’s Hospital specializes in meeting the unique physical, emotional and developmental...
Click here to add this to my saved trials
